Effects of Goji vs. Fiber on Macular Degeneration
GOJI
Effects of Goji Berry Intake on Risk of Age-related Macular Degeneration: A Randomized Clinical Trial
1 other identifier
interventional
60
1 country
1
Brief Summary
The goal of this project is to conduct a clinical trial in 60 participants ranging from age 65-95 who are at risk for age-related macular degeneration (AMD). The study will evaluate the effects of 14g of goji berry intake or an equivalent amount and type of fiber, five days a week for six months, on visual health, gut microbiome profiles, skin carotenoid measures, and lipoprotein profiles.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 19, 2024
CompletedFirst Posted
Study publicly available on registry
February 1, 2024
CompletedStudy Start
First participant enrolled
April 29, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2027
June 24, 2025
June 1, 2025
2.2 years
January 19, 2024
June 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Macular pigment optical volume (MPOV)
MPOV provides an objective measure of macular pigments by using dual wavelength autofluorescence using the Heidelberg Spectralis to obtain HRA + OCT measures
Day 0 and Day 180
Secondary Outcomes (13)
Stool microbiome
Day 0 and Day 180
Spectral Domain-Ocular Coherence Tomography (SD-OCT)
Day 0 and Day 180
Fundus autofluorescence (FAF)
Day 0 and Day 180
Color Fundus Photography (CFP)
Day 0 and Day 180
Microperimetry testing
Day 0 and Day 180
- +8 more secondary outcomes
Study Arms (2)
Goji berry
EXPERIMENTALFor the goji berry arm, participants will consume goji berries.
Fiber
ACTIVE COMPARATORFor the fiber arm, participants will consume fiber supplements that closely matches the fiber type and amount found in the portion of goji berries.
Interventions
Participants will be instructed to consume 14 grams of goji berries 5 days a week for 6 months
Participants will be instructed to consume the fiber supplements 5 days a week for 6 months
Eligibility Criteria
You may qualify if:
- Family history of AMD
- Hyperlipidemia or managed diabetes
- years of age
You may not qualify if:
- Dislike of, or allergy to, goji berries or any of the ingredients in the fiber-rich wafers and gummies (wheat, corn, oats, soy, natural orange flavor, xylitol, annatto, pectin, or other food ingredients)
- Consumption of \> 2 alcoholic drinks per day
- Indications of substance or alcohol abuse
- Current or planned use of a blood thinner (e.g., Coumadin, Warfarin) at any time during study
- Use of multi-vitamin or any other supplements that contain lutein and/or zeaxanthin (if willing to stop the supplement, subject can be enrolled 6 months from stop date)
- Any planned international travel during the study
- Consuming \>3 servings/day of a combination of spinach, kale, lettuce, orange bell peppers, corn, parsley, squash, broccoli, pumpkin, edamame
- Regularly consuming \>3 eggs/day
- Currently participating in any other interventional research study
- Diagnosed with inflammatory bowel disease, irritable bowel syndrome, other gastrointestinal disorder, undergoing cancer therapy or immunocompromised, or diagnosis of another condition where lutein, zeaxanthin and/or fiber supplementation would be contraindicated or would interfere with ability to participate in the study
- Any physical characteristic or condition that precludes ability to perform study procedures
- Medical or psychiatric condition that, in the opinion of the Investigator, would compromise study findings or prevent the participant from completing the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UC Davis Eye Center, Tschannen Eye Institute
Sacramento, California, 95817, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert M Hackman, PhD
University of California, Davis
- PRINCIPAL INVESTIGATOR
Angela M Zivkovic, PhD
University of California, Davis
- PRINCIPAL INVESTIGATOR
Glenn Yiu, MD, PhD
University of California, Davis
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Nutritionist
Study Record Dates
First Submitted
January 19, 2024
First Posted
February 1, 2024
Study Start
April 29, 2024
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
June 30, 2027
Last Updated
June 24, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share